Show simple item record

dc.contributor.authorWangdi, JT
dc.contributor.authorO'Leary, MF
dc.contributor.authorKelly, VG
dc.contributor.authorJackman, SR
dc.contributor.authorTang, JCY
dc.contributor.authorDutton, J
dc.contributor.authorBowtell, JL
dc.date.accessioned2021-11-16T10:50:33Z
dc.date.issued2021-11-10
dc.date.updated2021-11-16T08:51:16Z
dc.description.abstractINTRODUCTION: Montmorency cherry concentrate (MCC) supplementation enhances functional recovery from exercise, potentially due to antioxidant and anti-inflammatory effects. However, to date, supporting empirical evidence for these mechanistic hypotheses is reliant on indirect blood biomarkers. This study is the first to investigate functional recovery from exercise alongside molecular changes within the exercised muscle following MCC supplementation. METHODS: Ten participants completed two maximal unilateral eccentric knee extension trials following MCC or placebo supplementation for 7 days prior to and 48 hours following exercise. Knee extension maximum voluntary isometric contractions (MVC), maximal isokinetic contractions, single leg jumps, and soreness measures were assessed before, immediately, 24 and 48 h after exercise. Venous blood and vastus lateralis muscle samples were collected at each time point. Plasma concentrations of IL-6, TNF-α, C-reactive protein, creatine kinase, and phenolic acids were quantified. Intramuscular mRNA expression of SOD 1 and 3, GPX1, 3, 4 and 7, Catalase, and Nrf2 and relative intramuscular protein expression of SOD1, Catalase and GPX3 were quantified. RESULTS: MCC supplementation enhanced recovery of normalized MVC 1 s average compared to placebo (Post- Exercise PLA: 59.5 ± 18.0% vs MCC: 76.5 ± 13.9%; 24 h PLA: 69.8 ± 15.9% vs MCC: 80.5 ± 15.3%; supplementation effect p = 0.024). MCC supplementation increased plasma hydroxybenzoic, hippuric and vanillic acid concentrations (supplementation effect p = 0.028, p = 0.002, p = 0.003); SOD3, GPX3, GPX4, GPX7 (supplement effect p < 0.05) and GPX1 (interaction effect p = 0.017) gene expression; and GPX3 protein expression (supplementation effect p = 0.004) versus placebo. There were no significant differences between conditions for other outcome measures. CONCLUSION: MCC supplementation conserved isometric muscle strength and upregulated antioxidant gene and protein expression in parallel with increased phenolic acid concentrations.en_GB
dc.description.sponsorshipCherry Research Committeeen_GB
dc.description.sponsorshipQUEX Instituteen_GB
dc.identifier.citationPublished online 10 November 2021en_GB
dc.identifier.doihttps://doi.org/10.1249/MSS.0000000000002827
dc.identifier.urihttp://hdl.handle.net/10871/127822
dc.identifierORCID: 0000-0003-1845-9568 (O'Leary, Mary F)
dc.identifierScopusID: 57203072076 (O'Leary, Mary F)
dc.identifierResearcherID: I-2372-2019 (O'Leary, Mary F)
dc.language.isoenen_GB
dc.publisherLippincott, Williams & Wilkins / American College of Sports Medicine (ACSM)en_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/34772901en_GB
dc.rights.embargoreasonUnder embargo until 10 November 2022 in compliance with publisher policyen_GB
dc.rights© 2021 American College of Sports Medicineen_GB
dc.subjectPhenolic Acidsen_GB
dc.subjectResistance Exerciseen_GB
dc.subjectMuscle Damageen_GB
dc.subjectAntioxidanten_GB
dc.subjectOxidative Stressen_GB
dc.titleTart Cherry Supplement Enhances Skeletal Muscle Glutathione Peroxidase Expression and Functional Recovery after Muscle Damageen_GB
dc.typeArticleen_GB
dc.date.available2021-11-16T10:50:33Z
exeter.place-of-publicationUnited States
dc.descriptionThis is the author accepted manuscript. The final version is available from Lippincott, Williams & Wilkins via the DOI in this recorden_GB
dc.descriptionData availability statement: Data are available within the figures and tables of this manuscript and are also included in the statistical summary document.en_GB
dc.identifier.eissn1530-0315
dc.identifier.journalMedicine and Science in Sports and Exerciseen_GB
dc.relation.ispartofMed Sci Sports Exerc
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2021
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2021-11-10
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2021-11-16T10:47:53Z
refterms.versionFCDAM
refterms.dateFOA2022-11-10T00:00:00Z
refterms.panelCen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record